Doctor's Notes

Three-Year Symptom Follow-Up in 577 Commercial Pilots

Fictional illustration of an adult male pilot completing a post-flight log at an unbranded desk with the authentic Dr. Arsy #003 4 oz jar

Doctor’s Notes · Life in Motion · Primary-Study Review

Visual disclosure: The featured image is an AI-created illustration of a fictional adult workplace or activity scene combined with the authentic Dr. Arsy #003 packshot. It is not a patient, study participant, endorsement, diagnosis, before-and-after image or product result.

The exact question: What did PMID 25945663 measure in 577 stockholm-based commercial pilots at baseline; 436 participated at three-year follow-up., and what would go beyond the evidence?

Why this matters in a moving day

An adult male pilot completing a post-flight log at an unbranded desk is a specific context, not a diagnosis. Work pace, equipment, wetness, friction, climate, ultraviolet exposure, sleep and prior skin history can overlap. The paper below answers one narrow question; it does not turn every similar setting into the same outcome.

Study snapshot

Study element Reported detail
Population / denominator 577 Stockholm-based commercial pilots at baseline; 436 participated at three-year follow-up.
Design Prospective questionnaire cohort with multiple logistic and ordinal regression.
Comparator Changes in environmental tobacco smoke, route type, work demands, work control and home environment.
Timepoint 1997 baseline and 2000 follow-up.
Numerical finding Baseline participation was 577/622 (93%) and follow-up was 436/577 (76%); increased work demands predicted new dermal symptoms, while the abstract gives no dermal odds ratio.
Funding / conflicts Non-U.S. government support is indexed by PubMed; no conflict statement appears in the abstract.

What the study found

Baseline participation was 577/622 (93%) and follow-up was 436/577 (76%); increased work demands predicted new dermal symptoms, while the abstract gives no dermal odds ratio.

The cohort links changing work conditions to reported symptoms but cannot isolate a single exposure or confirm diagnoses.

The denominator is part of the result. A survey, clinical examination, environmental sample, instrument reading, case report and case-control estimate answer different questions. A reported symptom is not automatically a confirmed diagnosis, and a physiological change is not automatically disease.

Important limitations

Self-report, 24% cohort attrition, historical tobacco exposure and multiple work/home predictors.

These limitations do not erase the observation; they set its boundaries. Null results and uncertainty are retained because removing them would change the study’s meaning.

How to read the denominator, comparator and timepoint

The evidence base here is 577 stockholm-based commercial pilots at baseline; 436 participated at three-year follow-up. The study design was prospective questionnaire cohort with multiple logistic and ordinal regression. Its comparison was changes in environmental tobacco smoke, route type, work demands, work control and home environment. That combination determines what the numbers can answer. A result from this population should not be silently expanded to every worker, athlete, parent or person with sensitive skin, and an association should not be rewritten as proof of cause.

The reported time frame was 1997 baseline and 2000 follow-up. That matters because a single assessment, short intervention, long follow-up and case report each capture different parts of a moving routine. For an adult male pilot completing a post-flight log at an unbranded desk, the defensible use of this evidence is to observe the same concrete variables the researchers measured—task, exposure, fit, timing or environment—while keeping the original uncertainty visible. It is not evidence that a moisturizer changes the study outcome.

A careful decision boundary

The numerical result was: Baseline participation was 577/622 (93%) and follow-up was 436/577 (76%); increased work demands predicted new dermal symptoms, while the abstract gives no dermal odds ratio. The practical question is therefore not “Does this prove the job or activity causes a skin condition?” It is “What was observed in this defined group, under this comparison, at this timepoint?” That narrower question preserves both positive and null findings. It also helps separate routine dry-skin comfort from occupational disease, allergy, infection, ultraviolet injury or another condition that may require exposure control or professional assessment.

A practical observation log

  • Record the exact task, surface, garment, equipment, weather or room condition.
  • Note the body site and whether the pattern matches pressure, friction, wet work or exposure.
  • Record timing: before the shift, during the activity, after washing and after recovery.
  • Separate a visible sign from a sensation and from a clinician’s diagnosis.
  • Document changes in fit, cleaning products, protective equipment, workload, sleep or environment.

What this paper does not show

It does not show that every person in the same job or activity will have the reported outcome. It does not establish that Dr. Arsy #003 was studied, and it does not support substituting moisturizer for exposure control, fit correction, sun protection, infection precautions or medical assessment.

Primary and authoritative sources

Where Dr. Arsy #003 fits

Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. PMID 25945663 did not test #003. The study cannot be used to claim that #003 treats, cures or prevents eczema, allergy, infection, sun injury, occupational disease or cancer; relieves pain or itch; works for everyone; is proven safe for children; or provides unverified 24-hour protection.

Continue the Life in Motion evidence series

Search context: The campaign keyword workbook is used only as site-impression context; no market-wide search volume or ranking is claimed.

Educational evidence review, not individual medical advice or activity clearance. PubMed indexing is not NIH endorsement.

← Back to Doctor's Notes